MBA-P01
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MBA-P01, covering 2021-03-19 to 2024-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines [Phase 3]